Serological Response to COVID-19 Vaccination in Saudi Arabia: A Comparative Study of IgG and Neutralising Antibodies Across Vaccine Platforms

<b>Background</b>: In the Kingdom of Saudi Arabia, various COVID-19 vaccines were administered during the pandemic. However, region-specific real-word comparative data on their immunogenicity remain limited. This study aimed to assess the serological responses to Pfizer-BioNTech (BNT162b2), Moderna...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Mariam M. AlEissa, Ahdab A. Alsaieedi, Reema Alduaiji, Fahad Almsned, Yousif AlDossary, Nada Saleh, Raghad A. AlQurashi, Esraa A. Hawsa, Muath b Ben Shaded, Amer M. Alshehri, Osamah T. Khojah, Eyad Y. Abu Sarhan, Hamad H. Alonazi, Walid A. Nouh, Khalid H. AlAnazi, Sami S. Almudrra, Khaled I. AlAbdulkareem, Abdullah AlJurayyan, Abdullah M. Asiri
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	MDPI AG 2025-10-01
Cyfres:	Vaccines
Pynciau:	SARS-CoV-2 COVID-19 vaccine immunogenicity neutralising antibodies Saudi Arabia mRNA vaccine
Mynediad Ar-lein:	https://www.mdpi.com/2076-393X/13/10/1042
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!